Literature DB >> 10093992

Riboflavine and severe lactic acidosis.

R Luzzati, P Del Bravo, G Di Perri, A Luzzani, E Concia.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10093992     DOI: 10.1016/S0140-6736(99)00523-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

Review 1.  Stavudine: an update of its use in the treatment of HIV infection.

Authors:  M Hurst; S Noble
Journal:  Drugs       Date:  1999-11       Impact factor: 9.546

Review 2.  Treating HIV during pregnancy: an update on safety issues.

Authors:  D Heather Watts
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 3.  Adverse effects of antiretroviral therapy for HIV infection.

Authors:  Valentina Montessori; Natasha Press; Marianne Harris; Linda Akagi; Julio S G Montaner
Journal:  CMAJ       Date:  2004-01-20       Impact factor: 8.262

4.  Safety and efficacy of initiating highly active antiretroviral therapy in an integrated antenatal and HIV clinic in Johannesburg, South Africa.

Authors:  Vivian Black; Risa M Hoffman; Catherine A Sugar; Priya Menon; Francois Venter; Judith S Currier; Helen Rees
Journal:  J Acquir Immune Defic Syndr       Date:  2008-11-01       Impact factor: 3.731

5.  Antiretroviral Therapy-associated Serious and Life-threatening Toxicities.

Authors:  Alice K. Pau
Journal:  Curr Infect Dis Rep       Date:  2003-10       Impact factor: 3.663

Review 6.  Bench-to-bedside review: severe lactic acidosis in HIV patients treated with nucleoside analogue reverse transcriptase inhibitors.

Authors:  Yann-Erick Claessens; Jean-Daniel Chiche; Jean-Paul Mira; Alain Cariou
Journal:  Crit Care       Date:  2003-02-28       Impact factor: 9.097

7.  A case of lactic acidosis caused by stavudine in an AIDS patient.

Authors:  Byoung Chul Cho; Sang Hoon Han; Suk Hoon Choi; Jun Yong Choi; Kyung Hee Chang; Young Goo Song; June Myung Kim
Journal:  Korean J Intern Med       Date:  2004-03       Impact factor: 2.884

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.